Skip to main content
SpringerLink
Log in

Economic and Social Challenges of Dialysis During the COVID-19 Pandemic

  • Conference paper
  • First Online:
Digitalisation: Opportunities and Challenges for Business (ICBT 2022)

Part of the book series: Lecture Notes in Networks and Systems ((LNNS,volume 620))

Included in the following conference series:

  • 1345 Accesses

Abstract

Covid-19 is reported to have originated in Wuhan, China in December 2019. It slowly spread through the world causing global health problems. Having a high transmission rate the infection spread across the population affecting the most vulnerable. The worst affected world is those who had high-risk factors such as age hypertension, diabetes, chronic respiratory diseases, cancer, cardiovascular diseases and the like. Patients with end-stage renal disease were hit hard. These patients world vulnerable to covid-19 they are older and also have comorbidity. Their immune system is weak which makes them more vulnerable to infection. Moreover, patients with end-stage kidney disease need to visit the dialysis centres three times a week for around 4 h. Exposure to the dialysis centre made them more exposed to the infection. Many patients are treated simultaneously at these dialysis centres. The non-availability of an antiviral drug for covid-19 it makes more important to prevent the disease. The infection can be prevented by limiting exposure to the infected areas. Many guidelines have been issued by various bodies for the prevention and containment of the disease in these hemodialysis centres. European dialysis working group has published guidelines to prevent the spread of infection in hemodialysis centres. Despite the availability of vaccines, the immune system in the patient having end-stage kidney failure diseases responds poorly to the vaccine. Poor Immunity of dialysis Patients and the emergence of a variant of SARS-COV-19 calls for a booster dose in all the patients undergoing dialysis. Due to Covid-19 stress levels and anxiety levels among the patients increased. However, not much information is available on the mental health of the patients undergoing Haemodialysis during the Pandemic. This study is carried out to study the economic impact of the COVID-19 outbreak on patients undergoing haemodialysis in the city of Bengaluru, India.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Cockwell, P., Fisher, L.-A.: The global burden of chronic kidney disease. Lancet 395(10225), 662–664 (2020)

    Article  Google Scholar 

  • Hsu, C.M.: COVID-19 in dialysis patients: outlasting and outsmarting a pandemic. National Libr. Med. 98(6), 1402–1404 (2020)

    Google Scholar 

  • Gupta, S., Simon, K.I.: Mandated and voluntary social distancing during the Covid-19 epidemic: a review (2020)

    Google Scholar 

  • Lodge, M.D.S. Abeygunaratne, T.: Safely reducing haemodialysis frequency during the COVID-19 pandemic. National Libr. Med. 21(1) (2020)

    Google Scholar 

  • Da Silva, M., Lodge, T.A., et al.: Safely reducing haemodialysis frequency during the COVID-19 pandemic. BMC Nephrol. 21, 532 (2020). https://doi.org/10.1186/s12882-020-02172-2

    Article  Google Scholar 

  • Lim, R.S., Goh, S.M., Yeo, S.C.: Renal outcomes in immunoglobulin a nephropathy following COVID-19 vaccination: a retrospective cohort study (2022)

    Google Scholar 

  • Wickens, O., Chinnadurai, R., et al.: Investigating the utility of COVID-19 antibody testing in end-stage renal disease patients receiving haemodialysis: a cohort study in the United Kingdom. Litterature scientifique international sur la maladie a coronavirus 2019, 22(1), 154 (2021)

    Google Scholar 

  • Rastad, H.: Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease. Food Agric. Organ. United Nations 1(12), 261–272 (2020)

    Google Scholar 

  • Tuschen, K., et al.: Renal transplantation after recovery from COVID-19 - a case report with implications for transplant programs in the face of the ongoing corona-pandemic. National Libr. Med. 22(1), 251 (2021)

    Google Scholar 

  • Al Naamani, Z., Gormley, K., Noble, H.: Fatigue, anxiety, depression and sleep quality in patients undergoing haemodialysis. Re. Gate 22(1) (2021)

    Google Scholar 

  • Iqbal, S., Iqbal, A., Blair, K.A.A., et al.: Challenges faced by the patients on dialysis treatment in COVID-19 era and the possible solutions. Biomed. J. Sci. Techn. Res. 36, 28279–28282 (2021)

    Google Scholar 

  • Clin Invest, J.: Kidney diseases in the time of COVID-19: major challenges to patient care. J. Clin. Investig. 130(6), 2749–2751 (2020)

    Article  Google Scholar 

  • Geetha, S., Guganathan, M., Giridharan, G., et al.: Challenges faced by nursing and dialysis staffs during COVID-19 pandemic - tanker foundation a model organization. J. Biomed. Res. 2(6), 529–531 (2021)

    Google Scholar 

  • Suri, R.S., Antonsen, J.E., et. al.: Management of outpatient hemodialysis during the COVID-19 pandemic: recommendations from the canadian society of nephrology COVID-19 rapid response team. Can. J. Kidney Health Dis. (2020)

    Google Scholar 

  • Al Amin, S., Morrison, S.D., et al.: Challenges for Non-COVID patients with chronic kidney disease in Bangladesh: an observation during coronavirus disease pandemic, INQUIRY. J. Health Care Organ. Provision Financing 58 (2021)

    Google Scholar 

  • Yu, X.,·Jha, V., et al.: Should more patients with kidney failure bring treatment home? What we have learned from COVID-19 (2022)

    Google Scholar 

  • Malo, M.F., Affdal, A., et al.: Lived experiences of patients receiving hemodialysis during the COVID-19 pandemic: a qualitative study from the Quebec renal network. Kidney360, 3(6), 1057–1064 (2022)

    Google Scholar 

  • Kliger, A.S., Silberzweig, J.: COVID-19 and dialysis patients: unsolved problems in early 2021. J. Am. Soc. Nephrol. 32(5), 1018–1020 (2021)

    Article  Google Scholar 

  • Chan, A.S.W., Ho, J.M.C., Li, J.S.F., et al.: Impacts of COVID-19 Pandemic on psychological well-being of older chronic kidney disease patients. Frontiers 8, 666973 (2021)

    Google Scholar 

  • Mahalingasivam, V., Su, G., Iwagami, M., Davids, M.R., Wetmore, J.B., Nitsch, D.: COVID-19 and kidney disease: insights from epidemiology to inform clinical practice. Nat. Rev. Nephrol. 18, 485–498 (2022)

    Article  Google Scholar 

  • Alkhunaizi, A.M., Al-Mueilo, S.H., Atiyah, M.M., Alnasrallah, B.: Hemodialysis during lockdown due to coronavirus disease 2019 pandemic in Eastern Saudi Arabia. Saudi J. Kidney Dis. 32(3), 794–797 (2021)

    Article  Google Scholar 

  • Simon, K.: Non-COVID-19 health care visits declined dramatically as pandemic hit. News at IU Bloomington (2020). https://news.iu.edu/stories/2020/08/iub/releases/03-non-covid-19-health-care-declines-during-pandemic.html

  • Weiner, D.E., Watnick, S.G.: Hemodialysis and COVID-19: an Achilles’ heel in the pandemic health care response in the United States. Kidney Med. 2(3), 227–230 (2020)

    Google Scholar 

  • Jager, K.J., et al.: Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe. Kidney Int. 98(6), 1540–1548 (2020). https://doi.org/10.1016/j.kint.2020.09.006

  • Qirjazi, E., et al.: SARS-COV-2 shedding in dialysis patients with covid-19. Kidney Inte. Rep. (2021). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393503/. Accessed 16 Feb 2023

Download references

Author information

Authors and Affiliations

  1. Department of Management, Kristu Jayanti College, Autonomous, Bengaluru, 560048, Karnataka, India

    Jaspreet Kaur

  2. Department of Professional Accounting and Finance, Kristu Jayanti College, Autonomous, Bengaluru, 560048, Karnataka, India

    C. H. Madhavi Latha

Authors
  1. Jaspreet Kaur
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. H. Madhavi Latha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jaspreet Kaur .

Editor information

Editors and Affiliations

  1. Northern Cyprus Campus, Middle East Technical University, Kalkanlı, Türkiye

    Bahaaeddin Alareeni

  2. College of Business and Finance, Ahlia University, Manama, Bahrain

    Allam Hamdan

  3. University College of Bahrain, Manama, Bahrain

    Reem Khamis

  4. Lebanese American University, Beirut, Lebanon

    Rim El Khoury

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Kaur, J., Latha, C.H.M. (2023). Economic and Social Challenges of Dialysis During the COVID-19 Pandemic. In: Alareeni, B., Hamdan, A., Khamis, R., Khoury, R.E. (eds) Digitalisation: Opportunities and Challenges for Business. ICBT 2022. Lecture Notes in Networks and Systems, vol 620. Springer, Cham. https://doi.org/10.1007/978-3-031-26953-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-26953-0_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-26952-3

  • Online ISBN: 978-3-031-26953-0

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics

Search

Navigation